A smartphone tool may help cystic fibrosis patients survive the lung transplant waitlist

NCT ID NCT04687475

First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time

Summary

This trial tests whether a home monitoring tool — combining daily lung function measurements and symptom surveys — can help doctors better manage cystic fibrosis patients who are waiting for a lung transplant. The tool sends data to the clinic, which may trigger earlier adjustments to a patient's priority score for transplant. Ten adults with cystic fibrosis who are already listed for a lung transplant will use the tool and be followed to see if it improves their chances of getting a transplant in time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a clinical tool combining home spirometry and symptom surveys
What this could lead to
If it works, this tool could help doctors prioritize lung transplants for cystic fibrosis patients who need them most, potentially reducing deaths while on the waiting list.
What could go wrong
This is a very small pilot study with only 10 participants, so results may not apply broadly. The tool depends on patients having and using a home spirometer, which may limit its use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cleveland Clinic

    Cleveland, Ohio, 44195, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.